NF-Y Organizes the gamma -Globin CCAAT Boxes Region*

Chiara Liberati, Antonella RonchiDagger , Patricia Lievens, Sergio Ottolenghi§, and Roberto Mantovani§

From the Dipartimento di Genetica e di Biologia dei Microrganismi, Università di Milano, Via Celoria 26, 20133 Milano, Italy

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The CCAAT-binding activator NF-Y is formed by three evolutionary conserved subunits, two of which contain putative histone-like domains. We investigated NF-Y binding to all CCAAT boxes of globin promoters in direct binding, competition, and supershift electrophoretic mobility shift assay; we found that the alpha , zeta , and proximal gamma  CCAAT boxes of human and the prosimian Galago bind avidly, and distal gamma  CCAAT boxes have intermediate affinity, whereas the epsilon  and beta sequences bind NF-Y very poorly. We developed an efficient in vitro transcription system from erythroid K562 cells and established that both the distal and the proximal CCAAT boxes are important for optimal gamma -globin promoter activity. Surprisingly, NF-Y binding to a mutated distal CCAAT box (a C to T at position -114) is remarkably increased upon occupancy of the high affinity proximal element, located 27 base pairs away. Shortening the distance between the two CCAAT boxes progressively prevents simultaneous CCAAT binding, indicating that NF-Y interacts in a mutually exclusive way with CCAAT boxes closer than 24 base pairs apart. A combination of circular permutation and phasing analysis proved that (i) NF-Y-induced angles of the two gamma -globin CCAAT boxes have similar amplitudes; (ii) occupancy of the two CCAAT boxes leads to compensatory distortions; (iii) the two NF-Y bends are spatially oriented with combined twisting angles of about 100°. Interestingly, such distortions are reminiscent of core histone-DNA interactions. We conclude that NF-Y binding imposes a high level of functionally important coordinate organization to the gamma -globin promoter.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The CCAAT box is a widespread regulatory sequence found in promoters and enhancers of several genes (1), whose functional importance has been well established in different systems (2-12). NF-Y (also termed CBF) has an almost absolute requirement for these five nucleotides and a strong preference for additional flanking sequences (13, 14). Based on supershift experiments with anti-NF-Y antibodies, on competition analysis with the original Ea Y box oligo,1 or on the heteromeric nature of the DNA-binding complex, NF-Y has been identified as the CCAAT box activator in over 100 promoters (7-11, 14, 15). The CCAAT consensus derived statistically by Bucher (1) (RRCCAAT(C/G)(A/G)) fits well with the optimal NF-Y-binding site.

NF-Y is a ubiquitous heteromeric protein composed of three subunits, NF-YA, NF-YB, and NF-YC, all necessary for DNA binding (16, 17). The cloning of NF-Y genes from several species including yeast, maize, lamprey, and sea urchin, evidenced highly conserved domains (16-22). The NF-YA homology domain can be divided into subunit association and DNA-contacting subdomains (20). The N-terminal contains a hydrophobic and Gln-rich activation surface (18). The NF-YC gene has been recently cloned and is specular with respect to NF-YA, since the homology domain is at the N terminus, whereas the C-terminal 180 amino acids are rich in glutamines and hydrophobic residues. NF-YB and NF-YC tightly interact with each other, and their association is a prerequisite for NF-YA binding and sequence-specific DNA interactions (16, 22). Both the NF-YB- and NF-YC-conserved domains contain putative histone fold motifs. This motif, common to all core histones, is responsible for the formation of the histone octamer (24) and is composed of three alpha -helices, separated by short loops/strand regions, enabling histones to dimerize with companion subunits (24, 25). Recent experiments on the yeast HAP3 (26), NF-YB/CBF-A (27), and NF-YC/CBF-C (28) indicate that this 65 amino acid long motif is necessary for subunit interactions and DNA binding. NF-Y has additional interesting features as follows: (i) CCAAT boxes are not able to activate alone even if multimerized, but they increase the activity of neighboring enhancer motifs. (ii) NF-Y appears to increase the affinity of transcription factors for their target sequence (29). However, the exact mechanisms of transcriptional activation by NF-Y are still elusive.

Globin genes are transcribed in a tissue-specific and developmentally regulated manner by means of various regulatory elements in their clusters (30). In addition to the locus control regions which have been characterized in transgenic mice, the promoters of each globin gene contain sequences that usually impart tissue-specific control in transfection experiments. Several lines of reasoning point to CCAAT sequences as important elements in globin gene expression as follows: (i) they are present in all globin promoters; (ii) they have been remarkably conserved in different species at a fixed distance from the cap site; (iii) genomic footprinting of all globin promoters in erythroid cells showed invariable protection of CCAAT sequences in vivo, indicating binding of activators (31); (iv) the functional importance has been documented in the beta -, alpha -, zeta -, and epsilon -globin promoters (2-5, 15); (v) the gamma -globin duplicated CCAAT boxes are the target of mutations affecting developmental silencing of gamma -globin expression in adult life. In particular, strong genetic evidence suggests that point mutations in the CCAAT box region are causative of the HPFH syndromes, characterized by increased fetal globin levels in adults (32-37).

Several studies investigated factors binding to CCAAT; CDP, NFE3, and c/EBP appear to recognize different globin promoters (3, 32-36). One CCAAT-binding protein, alpha -CP1, was purified to homogeneity using an alpha -globin CCAAT box affinity column and found to be a trimeric factor most likely identical to NF-Y (15). Moreover, competition and supershift EMSA experiments performed with nuclear extracts determined that a CCAAT binding activity similar to NF-Y (termed CP1 in the globin field) binds to the gamma -globin promoters (32, 33). However, identification of CCAAT binding activities in other promoters is less certain; therefore, we wished to definitely determine which of the globin CCAAT boxes represents a bona fide NF-Y-binding site and establish a hierarchy of affinities. We then focused our attention on the highly regulated gamma -globin duplicated CCAAT box region. Because of the histone-like nature of NF-Y and its ability to distort DNA, we examined the possibility that NF-Y organizes this region.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Plasmid Constructions-- The starting plasmid for the circular permutation assays was pBend2 (14). The proximal and distal CCAAT box oligos described in Table I were inserted by blunt end ligation into the XbaI site. The double CCAAT and the phasing analysis oligos were also cloned into the XbaI site.

Plasmids for in vitro transcription (pAG1 and mutants thereof) were obtained by inserting the gamma -globin promoter (-299 to +35) into the PA101 vector (38). The SV40 promoter was excised by cutting with HindIII and BamHI, filling in with Klenow, and religating. Mutants were derived by polymerase chain reaction before cloning into PA101; pAG2 contains mutations in the distal CCAAT 3' region (-109 AGCC to GACT) that render it identical to the epsilon -globin CCAAT box. pAG3 has a mutation at position -86 of the proximal CCAAT (A to C). pAG4 contains a 13-bp deletion of the distal CCAAT (from -122 to -109). pAG5 harbors both the distal CCAAT-epsilon swap of pAG2 and the point mutation (- 86 A to C) of pAG3 in the proximal CCAAT. pAG6 contains a triple mutation (CCAAT to TCTAG) in both the distal and the proximal CCAAT boxes. All constructs were checked by sequencing.

Electrophoretic Mobility Shift Assay (EMSA)-- Labeled oligonucleotides (10,000 cpm) containing the different globin CCAAT boxes were incubated with K562 nuclear extracts (5 µg) for 30 min at 25 °C. Binding reactions for NF-Y were performed incubating labeled oligonucleotides for 20 min at 20 °C, in a buffer containing 5% glycerol, 50 mM NaCl, 20 mM Tris, pH 7.5, 0.5 mM EDTA, 5 mM MgCl2, and 1 mM dithiothreitol, and run in 4% polyacrylamide gels (acrylamide/bis-acrylamide ratio of 29:1) at 4 °C. Supershift experiments were performed as described in Ref. 12.

Competition experiments were performed following two different incubation procedures as described in Fig. 6: increasing concentrations (1, 3, 10, and 25 ng) of cold competitors were incubated either before addition of the labeled oligos (6000 cpm) or after 10 min of incubation of NF-Y with the probe.

Recombinant NF-YA9 and purified NF-YB/C were prepared as in Refs. 22 and 39. For circular permutation assays, NF-Y was incubated with end-labeled fragments generated by cuts with different enzymes (2000 cpm in each reaction). Fragments generated by the central XhoI digestions were used for the phasing analysis.

Calculations of Bending Angles-- Location of the points of flexure and amplitudes of the bending angles were described previously (14, 40). Briefly, the mobilities of the NF-Y-DNA complexes were normalized to the mobilities of the corresponding free DNA fragments; bending angles were calculated considering the ratio between the fastest and the slowest migrating complexes in EMSA, according to the formula mM/mE = cos a/2, where mM is the relative mobility of the complex exactly in the middle, mE is the relative mobility of the complex at the end of the fragment, and a is the angle of deviation. To determine bending centers, the normalized mobility of each NF-Y-DNA complex was plotted as a function of the distance between the center of the CCAAT sequence and the end of the DNA fragment; the bend was determined as the position at which the NF-Y-DNA complex was at a minimum.

In the phasing analysis, the mobility of the upper bands of the +3, Delta 3, and Delta 5 oligos was normalized for the mobility of the lower bands and plotted against that of the wt fragment. The best fitting equation and the R2 value were calculated by means of Microsoft Excel 7.

In Vitro Transcription-- Preparation of transcriptionally competent K562 nuclear extracts and in vitro transcription reactions were detailed in Ref. 38. Two independent CsCl plasmid preparations of the pAG vectors were used in different sets of experiments.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

NF-Y Binds to CCAAT Boxes of All Globin Promoters-- To determine which of the globin CCAAT boxes is recognized by NF-Y, we labeled oligonucleotides (see Table I) for EMSA experiments with nuclear extracts, challenging the resulting complexes with anti-NF-YB- and anti-NF-YA-purified antibodies (12). Bands of different mobilities and intensities are generated with all oligos (Fig. 1), with the alpha  (lanes 4-6), zeta  (lanes 8-10), hgamma P (human gamma proximal, lanes 16-18), ggamma P (prosimian Galago crassicaudatus gamma proximal, see Ref. 36, lanes 28-30), hgamma D (human gamma  distal, lanes 20-22) and ggamma D (G. crassicaudatus gamma  distal, lanes 32-34), one predominant shifted band is visible; these complexes are supershifted by specific anti-YB and anti-YAc antibodies (12). In each case we ran parallel migrations of the Y box oligo incubated with recombinant NF-YA and purified NF-YB/NF-YC; as shown in Fig. 1, the bands have electrophoretic behaviors identical to the endogenous K562 bands shifted by the anti-NF-Y antibodies. On the other hand, with the beta  and epsilon  CCAAT multiple bands are visualized (lanes 12-14 and 24-26); for the epsilon  a weak band comigrating with NF-Y and supershifted by the antibodies is observed, and for the beta  the four major bands detected have different mobilities compared with the Y/NF-Y band, and no supershift is evident. These data show that NF-Y binding is readily visualized on all globin CCAAT boxes and is the most prominent binding protein, with the exception of epsilon  and beta , which show a much higher affinity for proteins unrelated to NF-Y.

                              
View this table:
[in this window]
[in a new window]
 
Table I
List of oligonucleotides used in this study


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 1.   EMSA analysis of nuclear proteins binding to globin CCAAT boxes. The labeled oligos indicated above are incubated with K562 nuclear extracts (5 µg) in the absence (lanes 1, 4, 8, 12, 16, 20, 24, 28, and 32) or in the presence of purified anti-YAC or anti-YB antibodies. Purified NF-Y was run in parallel with the MHC Ea Y box oligo (lanes 7, 11, 15, 19, 23, 27, 31, and 35). Asterisks refer to the NF-E3 band visible on the epsilon -hgamma D and ggamma P CCAAT boxes, as described previously (32, 36)

To determine the relative affinity of NF-Y for each of the globin CCAAT boxes, we then incubated purified NF-YB/NF-YC and recombinant NF-YA with the different labeled oligos in the absence (Fig. 2, see lane 1) or in the presence of 20- and 100-fold excess of cold competing oligos containing the different CCAAT boxes examined above. Results are shown in lanes 2-19. Y box binding is efficiently competed only by zeta , whereas alpha  and the gamma P, both from human and Galago, have a somewhat lower affinity (see quantification of the data in Fig. 2B). All these CCAAT boxes clearly have a higher affinity in cross-competitions than epsilon  and the very low affinity beta . Note that the complex generated with the epsilon - and beta -globin CCAAT boxes is visible only after prolonged exposures (3 and 7 days, respectively, in the experiment shown). In general, all data are consistent with the fact that the better binders in direct EMSA are also the most avid competitors. Cross-competition experiments establish that the relative affinity of NF-Y for the different CCAAT boxes varies profoundly by more than 2 orders of magnitude, ranging from very high (zeta  and Y) to high (alpha , hgamma P, and ggamma P) to medium (ggamma D) to low (epsilon  and beta ).


View larger version (66K):
[in this window]
[in a new window]
 


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 2.   A, cross-competition analysis of globin CCAAT oligos. The indicated labeled oligos were incubated with purified NF-Y in the absence (lanes 1) or presence of a 20- (even numbers) or a 100-fold (uneven numbers) molar excess of the competing oligos (lanes 2-19). For the epsilon  and beta  oligos, long exposures of 60 h and 7 days, respectively, were necessary to visualize the NF-Y bands. B, quantification of the data in A were obtained by densitometric scanning of the gels.

Both gamma -Globin CCAAT Boxes Contribute to Promoter Activity in Vitro-- We next focused our attention on the developmentally regulated gamma -globin promoter. We fused the minimal tissue-specific gamma -globin promoter (-299 to +35) to a rabbit beta -globin reporter gene (plasmid pAG1) and generated mutants in the proximal or in the distal CCAAT boxes (see scheme in Fig. 3A). The wt and mutated constructs were tested in a functional in vitro assay with transcriptionally competent erythroid K562 extracts. RNA was purified and hybridized to a single-stranded end-labeled DNA probe; subsequent S1 mapping allowed the determination of qualitative and quantitative changes in the transcription rate. As an internal control we added a plasmid containing the adenovirus major late promoter TATA box devoid of any activating sequences and fused to the same reporter gene. Fig. 3B shows that our system efficiently transcribes the gamma -globin promoter and faithfully reproduces the correct start site used in vivo. We tested the different mutants: alteration of the proximal CCAAT box or destruction of the distal by a 13-base pair deletion (pAG3 and pAG4) decreases transcription 3-4-fold (Fig. 3C, lanes 3 and 4). Swapping the weak epsilon -globin CCAAT box into the distal CCAAT box position partially restores transcription when the proximal CCAAT is mutated, while having minor effects when the proximal CCAAT is intact (pAG2 and pAG5, respectively; Fig. 3C, lanes 1, 2 and 5). A mutant promoter containing mutations in both CCAAT boxes (pAG6) was also compared with wt pAG1 and resulted in the lowest transcriptional rate (6-fold down, compare Fig. 3C, lanes 6 and 7). Note that the signals in Fig. 3C result from a 4-h exposure. These data indicate that both CCAAT elements contribute to the optimal promoter activity. However, other important activators are probably operating, since mutations in the CCAAT boxes do not abolish transcription completely.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 3.   In vitro transcription analysis of the gamma -globin promoter. A, a scheme representing the different constructs used is depicted. All contained the gamma -globin promoter (-299/+35) fused to a rabbit beta -globin reporter. B, mapping of gamma -globin promoter-driven RNA by S1 analysis. In vitro transcriptions with 100, 200, and 400 ng of pAG1 plasmid were run in parallel with a sequencing reaction, to spot the transcriptional start site in our in vitro system. The signal corresponding to the probe is indicated. C, analysis of CCAAT box gamma -globin mutants. 200 ng of each plasmid and 4 µl of transcription extract (40 µg) was used for in vitro transcriptions, together with 50 ng of the pAL5 internal control, generating the correct gamma -globin +1 signal and the shorter beta -globin signal. Given 100 in arbitrary units the activity of pAG1 and pAG2 was 60, pAG3 was 33, pAG4 was 26, pAG5 was 24, and pAG6 was 16.

Binding of NF-Y to the gamma -Globin Double CCAAT Boxes Region-- By having shown that both gamma -globin CCAAT boxes bind NF-Y and are important for in vitro promoter activity, we investigated their interplay; we labeled a long oligo encompassing the two CCAAT boxes, incubating increasing concentrations of recombinant NF-Y, containing wt NF-YA and NF-YB and the homology domain of NF-YC. Fig. 4 shows that two bands of different electrophoretic mobility are generated (lanes 1-4); to ascertain whether the slow migrating complex corresponds to DNA fragments bound by two NF-Y molecules, we used fragments mutated in the distal CCAAT (C-114), in the proximal CCAAT (the corresponding C to T mutation at -87), or in both. We have deliberately chosen this mutation because genetic evidence strongly associates it with HPFH syndromes in humans (34). Mutations in such position are known to essentially abolish NF-Y binding to all CCAAT boxes tested so far, including the gamma -globin (13-15, 40).2 The faster complex is only modestly affected by mutations in the distal CCAAT; the slower complex is greatly diminished in the -87 CCAAT mutant and in the double mutant (compare lanes 4, 12 and 16). Surprisingly, the -114 mutant exhibited a considerable level of the upper complex (compare lanes 4 and 8 and see the calculated ratios in Fig. 4B). With the double mutant, both the slower and the faster complexes were also crippled (lanes 13-16). These data suggest that the faster band corresponds to NF-Y binding to either the proximal or the distal site, whereas the upper one results from double occupancy of the two CCAAT boxes. Interestingly, consistent with the cross-competition experiments, binding of NF-Y to the proximal CCAAT is predominant and compensates for a crippling mutation in the distal CCAAT, whereas the reverse is not true.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 4.   A, EMSA analysis of the double CCAAT box gamma -globin oligos. Dose-response of NF-Y with the wild type (lanes 1-4, 0.1, 0.3, 1, and 5 ng) or oligos with mutations (C to T in the second C of CCAAT) in the distal (lanes 5-8), proximal (lanes 9-12), or both CCAAT boxes. The bands corresponding to single and double occupation of the CCAAT boxes are indicated. B, quantification of the experiments in A. The upper/lower complex ratios are indicated above each mutant, except for DM, in which the upper complex was too weak to be quantitated. square , upper band; black-square, lower band.

To better understand the mechanisms leading to double occupancy and rule out the alternative explanation of the data in Fig. 4, namely that the upper band is due to formation of an NF-Y dimer on single CCAAT boxes, we rotationally moved the position of the two CCAAT by introducing short deletions of 3, 5, and 8 base pairs between them. Dose-response experiments were performed with labeled oligos; deletion of three nucleotides has relatively little effect on double binding, whereas a drop is observed with the Delta 5 and even more with the Delta 8 (Fig. 5, lanes 9-16); a Delta 11 deletion was also tested and showed essentially no upper complex (not shown). Thus, changing the rotational position of the two elements does not seem to increase double occupancy; rather, shortening the distance between CCAAT boxes by less than 24 base pairs progressively inhibits upper complex formation, while having no effect on the lower complex. From this set of EMSA we conclude that the upper complex is indeed due to simultaneous binding of NF-Y to the two CCAAT sequences.


View larger version (70K):
[in this window]
[in a new window]
 
Fig. 5.   EMSA analysis of short deletions between the CCAAT boxes. Dose-response of NF-YA/NF-YB/NF-YC5 was performed with either the wt oligo (lanes 1-4, 0.1, 0.3, 1 and 5 ng), or with oligos containing deletions of 3 (lanes 5-8), 5 (lanes 9-12) and 8 (lanes 13-16) nucleotides in the region between the CCAAT boxes.

We then wanted to verify whether NF-Y binding to the two sites is cooperative. To this aim, we employed two incubation procedures outlined in Fig. 6, A and B and C and D; increasing concentrations of cold high affinity Y box competitor were incubated either before addition of the labeled oligos, to prevent formation of NF-Y-CCAAT complexes (panels A and B), or after NF-Y-CCAAT binding (C and D). Results of the preincubation experiments on all labeled oligos showed that double NF-Y binding is decreased with equivalent efficiency compared with the single occupancy band (Fig. 6, A and B, lanes 1-5 and 11-15 and quantification in 6E). Parallel competitions performed with a mutated Y box cold oligo caused no decrease in either NF-Y bands (Fig. 6, A and B, lanes 6-10 and 16-20). However, the reverse order of addition gave different indications. For Delta 3 and Delta 8, the decrease of the upper band paralleled that of the lower complexes (Fig. 6, C and D, lanes 11-15); on the Delta 5 and, to a much lesser extent, the wt oligos, the double occupancy band was more resistant to competition than the single CCAAT-NF-Y (Fig. 6, C and D, lanes 1-5; see 6E). The latter result tends to suggest some form of cooperative behavior among the two NF-Y molecules on the Delta 5 CCAAT boxes and some interplay in the wt. However, upon turning the reciprocal rotational positions of the two CCAAT sequences by 80/100°, as in the Delta 3 and Delta 8, this effect is not observed.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 6.   EMSA competition analysis on oligos with CCAAT deletions. A, a 5-, 20-, 100-, and 500-fold molar excess of competing wt (lanes 2-5 and 12-15) or mutated Y box oligos (lanes 7-10 and 17-20) were incubated with NF-YA/NF-YB/NF-YC5 (5 ng) before addition of the wt and Delta 3 labeled oligos (see scheme). B, same preincubation as in A, except that labeled Delta 5 and Delta 8 oligos were used. C, same as A except that the labeled wt and Delta 3 oligos were first incubated with NF-YA/NF-YB/NF-YC5 (22) and then challenged with the competing oligos (see scheme). D, same as B, except that the same order of addition as in C was used. For the Delta 5 and Delta 8 experiments a 10-fold higher amount of NF-Y was necessary to visualize the upper NF-Y bands. E, quantification of the data in A-D.

NF-Y Induces Bending of gamma -Globin CCAAT Boxes-- We have recently shown that NF-Y is able to induce distortions in the double helix, with angles that vary depending on the surrounding sequences (14). By using the circular permutation assay we checked the degree of distortion of the proximal and distal CCAAT boxes separately. We cloned the two oligos of identical length in the pBend2 vector (14); we then cut with different enzymes so that the CCAAT boxes were at different distances from the extremities of the fragments, and we performed EMSA with NF-Y. To calculate precisely the angles, we maximized the differences in mobilities of the protein-DNA complexes, using the small NF-YA9 mutant and purified endogenous NF-YB/NF-YC. We have shown that such combination does not alter significantly the distortion angles of four NF-Y sites (14). Clear indication that NF-Y induces distortions on both gamma -globin CCAAT boxes was evident from the different electrophoretic mobilities of the fragments (Fig. 7). Calculations of the angles gave similar results for both sites, and the values, 66° and 72° for distal and proximal, respectively, are similar to those observed for the murine sarcoma virus and epsilon -globin and slightly lower than for the Ea Y box and HSP70 NF-Y-binding sites. As expected, the flexures are indeed centered on the CCAAT sequences (Ref. 14 and data not shown).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 7.   Circular permutation assay of NF-Y CCAAT complexes. The pBend2 gamma -CCAAT plasmids were digested with the indicated enzymes, generating the fragments outlined in the underlying cartoon. They were incubated with NF-YA9/NF-YB/NF-YC (14). Lanes 1-5, proximal CCAAT; lanes 6-10, distal CCAAT; lanes 11-15, double CCAAT.

To verify the effect of two bound NF-Y molecules on the overall distortion, we then repeated the circular permutation experiments with the long gamma -globin oligo (Fig. 7). As expected, two bands are visible in EMSA. (i) The lower corresponds to occupancy of either the distal or the proximal CCAAT and is therefore a mixture of proximal and distal NF-Y binding. The arch formed by these bands is very similar to the one observed in circular permutation assays with the single CCAAT. Note, however, that in some of the lateral fragments the shifted bands are rather wide; since the distances from the extremities of the proximal versus the distal CCAAT are different, we do expect to see slightly altered electrophoretic behaviors. (ii) The upper complex mobilities are much more similar, with a calculated overall angle of 45°, suggesting compensation; much bigger differences between the fragments would have been scored had NF-Y bending angles been additive. Nonetheless, despite the presence of the two sites on opposite sides of the double helix (they are separated by 27 bp, hence 2.5 helical turns), a perfect straightening of the helix is not observed, as judged by this circular permutation EMSA, as one might have expected considering that the amplitudes of the two angles are nearly identical.

Phasing Analysis of CCAAT Boxes-- To verify whether NF-Y induces directed bends, as suggested by the previous experiment, and to seek further information about the relative distortions of the CCAAT region, we performed phasing analysis. This assay is usually tackled with appropriate vectors containing a fixed angle of known curvature, obtained exploiting the distortions caused by short AT-rich sequences spaced by one turn of the helix (Ref. 40 and references therein). Having fixed one angle, the binding site is rotationally moved on different sides of the double helix, by increasing the distance from the fixed angle, taking into account that one turn corresponds to 10.5 base pairs. The relative mobilities of the protein-bound complexes give clues about the orientation of the angles. Rather than adopting this strategy, which would give information about one isolated CCAAT, we took advantage of the two gamma -globin-binding sites with their previously calculated distortions. We cloned in pBend2 the Delta 3, Delta 5, Delta 8 oligos, and a +3 oligo, in which we added 3 bp between the two CCAAT. Cutting the resulting plasmids with any of the enzymes generates nearly identical fragments with NF-Y-binding sites rotationally displaced with respect to the wt situation. EMSA analysis of the central XhoI fragments is shown in Fig. 8, and comparable amounts of protein generated the single occupancy band with identical electrophoretic mobility for all fragments. The double occupancy band is visible with the +3, wt, and Delta 3 fragments, with the Delta 5 only after prolonged exposures, and is absent in the Delta 8. The mobilities of the latter bands are different, a clear indication that indeed the DNA is oriented upon NF-Y binding (40). The slowest fragment should be the one in which the two bends are in phase with respect to the helical turn of DNA, whereas the fastest is the one in which the two bends are facing opposite sides and counteract each other; the +3, in which the two CCAAT boxes are only 1.5 bp away from perfect alignment on the same side of the helix, is the slowest, and the Delta 3 and Delta 5 are the fastest. This is consistent with overall distortion angles of about 100° among the two CCAAT in the wt configuration (see Fig. 9). These results are indeed confirmed by experiments with a "mini" NF-Y protein (22) that is able to generate double bands in the Delta 8 as well, which give a phasing "period" of about 8 bp, corresponding to a rotation of about 100°.3


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 8.   Phasing analysis of NF-Y binding to the double CCAAT box. The wt, +3, Delta 3, Delta 5, and Delta 8 pBend2 vectors were digested with XhoI and the fragments incubated with NF-Y9/NF-YB/NF-YC. The band corresponding to double occupancy in the Delta 5 was visible after prolonged exposures. The mobility of the upper bands of the +3, Delta 3, and Delta 5 was plotted against that of the wt fragment as indicated in the underlying scheme.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 9.   The promoter targets of NF-Y in the globin clusters and the NF-Y-induced distortions in the gamma -globin CCAAT box region.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

In this study we undertook a systematic analysis of NF-Y binding to the CCAAT boxes of globin gene promoters and established that most, but not all, contain bona fide high affinity sites. We focused then on the human gamma -globin, and we developed an efficient in vitro functional assay with K562 extracts and provided for the first time evidence that both CCAAT boxes add to the overall level of expression. NF-Y binds better to the proximal than to the distal site, and DNA binding is neither cooperative nor mutually exclusive. The bending angles of the isolated CCAAT boxes are similar, and double binding induces compensatory alterations; the combined twisting angles are about 100°.

NF-Y and the Globin CCAAT Boxes-- Previous experiments with nuclear extracts identified several proteins binding to the CCAAT boxes of various globin promoters. CDP binds to the duplicated gamma -globin CCAAT box region (32, 33), NF-E3 to the gamma  distal CCAAT box and to the epsilon  box (32, 36), and c/EBP to the beta  CCAAT (3). The epsilon  CCAAT box region is bound by a number of factors (36). Binding of NF-Y has been more than suspected; the alpha -globin CCAAT box has been shown to recognize a multimeric factor (alpha -CP1) which by several criteria is NF-Y (15). The gamma  CCAAT boxes were also shown to be cross-competed by the Ea Y box (32, 33). By performing a systematic EMSA analysis on all globin CCAAT boxes with NF-Y, we found that the alpha , zeta , and proximal gamma  CCAAT bind NF-Y efficiently, the distal gamma CCAAT well, whereas the affinity for epsilon  and beta  is so low that we consider it unlikely that they are in vivo targets for NF-Y. A good binding site for NF-Y requires two additional conserved nucleotides at the 5' and three at the 3' (13, 41). As in all high affinity sites, two purines are present in all globin sites at the 5' end, indicating that sequences at the 3' end are responsible for the dramatic variations in affinities; the T at second position of the 3' end of beta  deviates from the consensus and is severely underrepresented in over 178 bona fide NF-Y-binding sites (41). Within the gamma -globin promoters, both in human and in the prosimian G. crassicaudatus, we note that the third position at the 3' end is the only different nucleotide among the distal and proximal CCAAT of human and Galago (see Table I), surprisingly pointing to this position, relatively distant to the core pentanucleotide, as important in affinity determination.

The bending analysis on the distal and proximal CCAAT gives values that are very similar, 66° for the distal and 72° for the proximal. This is not surprising since differences in amplitudes have been shown to be due to nucleotides flanking the pentanucleotide, which are almost identical. The circular permutation experiments on the long double CCAAT oligo show that binding of two NF-Y molecules are compensating in term of the overall angle, as shown in Fig. 9, with a combined angle of 45°. This value should be reconciled with the fact that the gamma -globin CCAAT boxes, being separated by 27 bp, lie on opposite sides of the double helix and that the flexure centers of the two isolated boxes are identical. Our phasing analysis establishes that NF-Y does orient DNA upon binding, determining that the overall relative distortion angles between two NF-Y-bound CCAAT boxes are of about 100°. Since the angle amplitudes are nearly identical, we conclude that the latter value results from the combination of simultaneous twisting of the double helix by angles of 40/50° for each of the two CCAAT boxes; this is in excellent agreement with the value -45° obtained in the circular permutation assay on double NF-Y binding. Our assays did not allow us to understand whether the flexures are toward the major or the minor groove, as might have been inferred from vectors containing angles with predetermined amplitudes and orientation (41). It is noteworthy, however, that the NF-Y data obtained here are remarkably similar in terms of angle amplitudes, bending and twisting, to core histones bound to DNA in nucleosomal structures, as determined by crystallographic studies (24). It should be pointed out that the histone-fold containing NF-Y subunits contact DNA directly and that this is elicited, in part, through minor groove contacts (14), another feature reminiscent of histones (24). Moreover, recent experiments indicate that NF-Y is able to bind very efficiently to nucleosomal templates.4 Therefore, one prediction from our studies is that at least part of the NF-Y-CCAAT interactions will follow rules similar to the ones described for histone-DNA contacts.

A surprising result of our EMSA is that the C-114 to T CCAAT mutation, while having a drastic effect on NF-Y binding to the isolated distal CCAAT (34), is much less crippling in the context of the double CCAAT, indicating that binding of NF-Y to the proximal site improves distal CCAAT recognition. The opposite is less true. The equivalent proximal C-87 to T mutation abolishes double binding almost completely. The "helping" behavior of the proximal CCAAT could in theory be due to (i) a stabilizing effect of direct protein-protein interactions or (ii) an indirect effect determined by DNA distortions (bending and twisting) generated by proximal CCAAT occupancy. Given the histone-like nature of NF-YB/NF-YC, interactions among different NF-Y molecules bound to DNA are certainly a possibility. However, competition experiments are consistent with a cooperative effect of double binding of NF-Y only for the Delta 5 mutant. Rather, we favor the second hypothesis; experiments presented by Jackson et al. (42) suggest that NF-Y binding dramatically increases the affinity of SREBP-1a for its neighboring target site, without even forming a stable ternary complex on the DNA. With this line of reasoning, mutations of the distal CCAAT might alter the reciprocal interplay between the two NF-Ys, and possibly the association with additional neighboring factors, rather than the affinity of NF-Y for the CCAAT sequence per se.

Role of CCAAT Boxes in gamma -Globin Transcription-- The efficient in vitro transcription system for the gamma -globin promoter allowed us to determine the role of the CCAAT boxes. Our data are consistent with the idea that both NF-Y-binding sites contribute to the optimal activity, and mutations in both CCAAT resulted in transcription levels that were lower (6-fold) than alterations in either CCAAT alone. A point mutation in the proximal and removal of the distal CCAAT box led to a comparable 4-fold decrease in transcription; and swapping an epsilon -like CCAAT box, which is a poor NF-Y-binding site, in the place of the distal gamma  CCAAT weakens the promoter both when the proximal CCAAT is intact (2-fold) and even more if it is mutated, as in pAG5. Thus, from the functional point of view, the twin CCAAT boxes seem to have an additive rather than a multiplicative effect, a result that is in line with the lack of cooperativity between the two proteins observed in the binding assays. Either CCAAT is nevertheless sufficient to impart rather efficient levels of transcription. This might be entirely due to strong TATA box and basal elements or to the activity of additional upstream factors, as suggested by challenging transcription with anti-GATA antibodies.5

Recent findings by Ronchi et al. (37) with mutated gamma -globin CCAAT boxes in transgenics suggested that they are important for gamma -globin expression in the adult (-117 HPFH mutation) but redundant in the embryonic/fetal period; mutations in the distal or in the proximal sites do not prevent efficient embryonic expression of the normal gamma -globin gene, a clear indication that additional strong activators are indeed operating. These findings are in sharp contrast with the data obtained in another transgenic system; removal of the Y box from the MHC class II Ea promoter dramatically decreases transcription, altering start site selection (43). In MHC class II promoters, NF-Y was shown to help the binding of the neighboring X-binding proteins, and cooperation between the two complexes is strictly necessary for efficient activation (29). The less profound effect of CCAAT mutations observed in the gamma -globin system is reminiscent of the albumin promoter, in which NF-Y contributes to in vitro transcription rates by a factor of 3 (12). One possible explanation for these observations is that complex, highly efficient promoters, such as globins and albumin, rely on multiple activators and might be less critically dependent on a single factor, whereas in the simpler MHC class II system NF-Y plays a more fundamental role. We favor a scenario in which NF-Y might have distinct roles depending on the promoter context; in Ea it would directly participate in the formation of a pre-initiation complex and ultimately help choosing the start site, in conjunction with an Initiator element (12, 44); in globin promoters it might help build the overall architecture and the proper interactions of additional DNA binding activators.

NF-Y might also have a direct influence on the developmental regulation of globin promoters; the fact that the alpha -like promoters have among the most avid NF-Y-binding sites and somewhat simpler promoters suggests a less refined level of regulation. Recent transgenic experiments on the human zeta  showed that 67 base pairs, including only the NF-Y-binding CCAAT box and TATA box, are sufficient to direct LacZ expression in erythroid cells in the correct developmental period (5). In the beta -like locus, whose genes are switched on and off three times, the very low affinity CCAAT boxes of embryonic epsilon  and adult beta  genes are most likely not the target of NF-Y. The hemoglobin switching model based on promoter competition proposed by Grosveld and colleagues (30) predicts that transcription complexes formed on the differentially expressed globin promoters play a fundamental role, being alternatively connected with locus control regions. As a result of the combined CCAAT bending and twisting, activators binding to the more distal CCAAC, GATA, and -200 regions might be brought closer to the TATA box and to the basal transcriptional machinery. Indeed evidence that NF-Y subunits can interact with TATA-binding protein has been recently obtained (45).

Consistent with this hypothesis are two findings, the "stage selector" element found between the CCAAT and TATA boxes (46) and the occurrence of several mutations (mostly point mutations) in alleles associated with persistence of fetal hemoglobin in adults (HPFH). Three such alterations, HPFH -117, -114, and Delta 13, involve the distal CCAAT box region. Our results on NF-Y binding to the -114 mutation in the context of the double CCAAT boxes help explain the apparent discrepancy of a crippling mutation in a functionally important element, retaining functional activity; based on the positive effect of the proximal CCAAT, we anticipate only minor consequences of the -114 for the total effectiveness of the mutant promoter. Nonetheless, HPFH subtle alterations might alter the fine interplay of factors involved in the developmental regulation of the gamma  gene, by modifying the bending and twisting of reciprocal angles.

NF-Y Binding to Duplicated CCAAT Boxes-- CCAAT boxes show a strong position bias within promoters being usually positioned between -60 and -100 (1). Functional experiments indicated that a single CCAAT box is not able to increase transcription over basal levels, and multimerized CCAAT boxes also fail to do so. NF-Y can greatly improve the activity of diverse upstream transcription factors, and in some cases, it has been proved that it does so by dramatically improving the affinity of neighboring factors for their target DNA sequence (29, 42). Since no data were available on the binding of NF-Y in promoters harboring more than one CCAAT box, the gamma -globin represents an excellent model to study their relationship. Several findings in our study bear implications for other systems as follows: (i) bringing two CCAAT sequences closer than 24 base pairs essentially abrogates double binding, and (ii) NF-Y complexes are more stable on the DNA only with the Delta 5 mutant, a deletion bringing the two CCAAT boxes on the same side of the helix. This suggests that cooperativity is possible, provided that the correct rotational position is respected. From the long list of CCAAT-containing promoters activated by NF-Y, a growing number contains two or more sites (see Table II); we note that in all, bar the gp91phox, the distance between the two NF-Y sites is greater than 27 nucleotides; in three cases, cdc2, H2b, and TK, it is of 30-32 bp, so that the two CCAAT face the same side of the helix. Most promoters have more distant sites (40/80 bp apart), and it is not known at present whether NF-Y complexes could influence each other at such distances. The only apparent exception is the gp91phox promoter, in which two CCAAT boxes are separated by only 14 nucleotides; however, while the proximal CCAAT box has been formally proven to be a bona fide NF-Y site, the distal CCAAT box appears to bind NF-Y poorly and is possibly targeted by other proteins. In conclusion, wherever CCAAT boxes closer than 24 base pairs are found, binding of NF-Y should be considered as mutually exclusive, or one of them is presumably activated by proteins other than NF-Y. Simultaneous binding of NF-Y to sites with multiples of 10.5 bp might be considered as more stable. Experiments aimed at verifying such hypotheses with our EMSA systems are currently underway. The assays described here, binding, bending, and phasing, will also be used in testing the effect of HPFH mutations in the distal CCAAT region on NF-Y binding.

                              
View this table:
[in this window]
[in a new window]
 
Table II
A list of multiple CCAAT-containing promoters

    ACKNOWLEDGEMENT

We thank L. Cairns for reviewing the manuscript.

    FOOTNOTES

* This work was supported in part by grants from Murst (to R. M. and S. O.), Telethon Grant E596 (to A. R.), EEC Biotec, and from Fondazione Italiana L. Giambrone per la Guarigione della Talassemia.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported by Fondazione L. Giambrone.

§ To whom correspondence should be addressed. Tel.: 39-2-26605239/26605225; Fax: 39-2-2664551; E-mail:mantor{at}imiucca.csi.unimi.it.

1 The abbreviations used are: oligos, oligonucleotides; HPFH, hereditary persistence of fetal hemoglobin; bp, base pair(s); EMSA, electrophoretic mobility shift assay; MHC, major histocompatibility complex; wt, wild type.

2 A. Ronchi, unpublished observations.

3 C. Liberati, S. Ottolenghi, and R. Mantovani, manuscript in preparation.

4 M. C. Motta and R. Mantovani, manuscript in preparation.

5 R. Mantovani, unpublished observations.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

  1. Bucher, P. (1990) J. Mol. Biol. 212, 563-578[Medline] [Order article via Infotrieve]
  2. Cowie, A., and Myers, R. M. (1988) Mol. Cell. Biol. 8, 3122-3128[Medline] [Order article via Infotrieve]
  3. Delvoye, N. L., Destroismaisons, N. M., and Wall, L. A. (1993) Mol. Cell. Biol. 13, 6969-6983[Abstract]
  4. Mason, M. M., Grasso, J. A., Gavrilova, O., and Reitman, M. (1996) J. Biol. Chem. 271, 25459-25467[Abstract/Free Full Text]
  5. Pondel, M. D., Sharpe, J. A., Clark, S., Pearson, L., Wood, W. G., and Proudfoot, N. J. (1996) Nucleic Acids Res. 24, 4158-4164[Abstract/Free Full Text]
  6. Bienz, M., and Pelham, H. R. B. (1986) Cell 45, 753-760[Medline] [Order article via Infotrieve]
  7. Li-Weber, M., Davydov, I. V., Krafft, H., and Krammer, P. H. (1994) J. Immunol. 153, 4122-4133[Abstract/Free Full Text]
  8. Osawa, H., Robey, R. B., Printz, R. L, and Granner, D. K. (1996) J. Biol. Chem. 271, 17296-17303[Abstract/Free Full Text]
  9. Ruddel, A. (1995) Virology 206, 1-7[Medline] [Order article via Infotrieve]
  10. Skalnik, D. G., Strauss, E. C., and Orkin, S. H. (1991) J. Biol. Chem. 266, 16736-167744[Abstract/Free Full Text]
  11. Spear, D. H., Ericsson, J., Jackson, S. M., and Edwards, P. A. (1994) J. Biol. Chem. 269, 25212-25218[Abstract/Free Full Text]
  12. Mantovani, R., Pessara, U., Tronche, F., Li, X. Y., Knapp, A. M., Pasquali, J. L., Benoist, C., and Mathis, D. (1992) EMBO J. 11, 3315-3322[Abstract]
  13. Dorn, A., Bollekens, J., Staub, A., Benoist, C., and Mathis, D. (1987) Cell 50, 863-872[Medline] [Order article via Infotrieve]
  14. Ronchi, A., Bellorini, M., Mongelli, N., and Mantovani, R. (1995) Nucleic Acids Res. 23, 4565-4572[Abstract]
  15. Kim, C. G., and Sheffrey, M. (1990) J. Biol. Chem. 265, 13362-13369[Abstract/Free Full Text]
  16. Sinha, S., Maity, S. N., Lu, J., and de Crombrugghe, B. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1624-1628[Abstract]
  17. Hahn, S., Pinkham, J., Weil, R., Miller, R., and Guarente, L. (1988) Mol. Cell. Biol. 8, 655-663[Medline] [Order article via Infotrieve]
  18. Hooft van Huijsduijnen, R., Li, X. Y., Black, D., Matthes, H., Benoist, C., and Mathis, D. (1990) EMBO J. 9, 3119-3127[Abstract]
  19. Li, X.-Y., Mantovani, R., Hooft van Huijsduijnen, R., Andre, I., Benoist, C., and Mathis, D. (1992) Nucleic Acids Res. 20, 1087-1091[Abstract]
  20. McNabb, D. S., Xing, Y., and Guarente, L. (1995) Genes Dev. 9, 47-58[Abstract]
  21. Pinkham, J. L., Olesen, S., and Guarente, L. (1987) Mol. Cell. Biol. 7, 578-585[Medline] [Order article via Infotrieve]
  22. Bellorini, M., Zemzoumi, K., Farina, A., Berthelsen, J., Piaggio, G., and Mantovani, R. (1997) Gene (Amst.) 193, 119-125[CrossRef][Medline] [Order article via Infotrieve]
  23. Li, X.-Y., Hooft van Huijsduijnen, R., Mantovani, R., Benoist, C., and Mathis, D. (1992) J. Biol. Chem. 267, 8984-8990[Abstract/Free Full Text]
  24. Arents, G., and Moudrianakis, E. N. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 10489-10493[Abstract]
  25. Arents, G., and Moudrianakis, E. N. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11170-11174[Abstract]
  26. Xing, Y., Fikes, J. D., and Guarente, L. (1993) EMBO J. 12, 4647-4655[Abstract]
  27. Sinha, S., Kim, I.-S., Sohn, K. Y., deCrombrugghe, B., and Maity, S. N. (1996) Mol. Cell. Biol. 16, 328-337[Abstract]
  28. Kim, I.-S., Sinha, S., deCrombrugghe, B., and Maity, S. N. (1996) Mol. Cell. Biol. 16, 4003-4013[Abstract]
  29. Reith, W., Siegrist, C.-A., Durand, B., Barras, E., and Mach, B. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 554-558[Abstract]
  30. Grosveld, F., Antoniou, M., Berry, M., deBoer, E., Dillon, N., Ellis, J., Fraser, P., Hurst, A., Imam, A., Meijer, D., Philipsen, S., Pruzina, S., Stroubulis, J., and Whyatt, D. (1993) Cold Spring Harbor Symp. Quant. Biol 58, 7-13[Medline] [Order article via Infotrieve]
  31. Reddy, P. M., Stamatoyannopoulos, G., Papayannopoulou, T., and James Shen, C.-K. (1994) J. Biol. Chem. 269, 8287-8295[Abstract/Free Full Text]
  32. Mantovani, R., Superti-Furga, G., Gilman, J., and Ottolenghi, S. (1989) Nucleic Acids Res. 17, 6681-6691[Abstract]
  33. Superti-Furga, G., Barberis, A., Schaffner, G., and Busslinger, M. (1988) EMBO J. 7, 3099-3107[Abstract]
  34. Fucharoen, S., Shimizu, K., and Fukumaki, Y. (1990) Nucleic Acids Res. 18, 5245-5253[Abstract]
  35. Berry, M., Grosveld, F., and Dillon, N. (1992) Nature 358, 499-502[CrossRef][Medline] [Order article via Infotrieve]
  36. Ronchi, A., Bottardi, S., Mazzucchelli, C., Ottolenghi, S., and Santoro, C. (1995) J. Biol. Chem. 270, 21934-21941[Abstract/Free Full Text]
  37. Ronchi, A., Berry, M., Raguz, S., Imam, A., Yannoutsos, N., Ottolenghi, S., Grosveld, F., and Dillon, N. (1996) EMBO J. 15, 143-149[Abstract]
  38. Mantovani, R. (1994) Methods Mol. Biol. 31, 289-298[Medline] [Order article via Infotrieve]
  39. Mantovani, R., Li, X. Y., Pessara, U., Hooft van Huijsduijnen, R., Benoist, C., and Mathis, D. (1994) J. Biol. Chem. 269, 20340-20346[Abstract/Free Full Text]
  40. Kerrpola, T., and Curran, T. (1991) Cell 66, 316-327
  41. Mantovani, R. (1998) Nucleic Acids Res. 26, 1135-1143[Abstract/Free Full Text]
  42. Jackson, S. M., Ericsson, J., Mantovani, R., and Edwards, P. A. (1998) J. Lipid Res. 10, 1-10[Abstract/Free Full Text]
  43. Benoist, C., and Mathis, D. (1990) Annu. Rev. Immunol. 8, 681-715[CrossRef][Medline] [Order article via Infotrieve]
  44. Bellorini, M., Dantonel, J.-K., Yoon, J.-B., Roeder, R. G., Tora, L., and Mantovani, R. (1996) Mol. Cell. Biol. 16, 503-512[Abstract]
  45. Bellorini, M., Lee, D.-K., Dantonel, J.-K., Zemzoumi, K., Roeder, R. G., Tora, L., and Mantovani, R. (1997) Nucleic Acids Res. 25, 2174-2181[Abstract/Free Full Text]
  46. Jane, S. M., Nienhuis, A., and Cunningham, J. M. (1995) EMBO J. 14, 97-105[Abstract]
  47. Chang, Z. F., and Liu, C. J. (1994) J. Biol. Chem. 269, 17893-17898[Abstract/Free Full Text]
  48. Zwicker, J., Lucibello, F. C., Wolfraim, L. A., Gross, C., Truss, M., Engeland, K., and Muller, R. (1995) EMBO J. 14, 4514-4522[Abstract]
  49. Zwicker, J., Gross, C., Lucibello, F. C., Truss, M., Ehlert, F., Engeland, K., and Muller, R. (1995) Nucleic Acids Res. 23, 3822-3830[Abstract]
  50. Isaacs, R. J., Harris, A. L., and Hickson, I. D. (1996) J. Biol. Chem. 271, 16741-16747[Abstract/Free Full Text]
  51. Schweizer-Groyer, G., Groyer, A., Cadepont, F., Grange, T., Baulieu, E. E., and Pictet, R. (1994) Nucleic Acids Res. 22, 1583-1592[Abstract]
  52. Hsiao, K. M., McMahon, S. L., and Farnham, P. J. (1994) Genes Dev. 8, 1526-1537[Abstract]
  53. Barberis, A., Superti-Furga, G., and Busslinger, M. (1987) Cell 50, 347-359[Medline] [Order article via Infotrieve]
  54. Osborne, T. F., Gil, G., Goldstein, J. L., and Brown, N. S. (1988) J. Biol. Chem. 263, 3380-3387[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.